KROS vs AAPL: Which Stock is Better?
Side-by-side comparison of Keros Therapeutics Inc and Apple Inc in 2026
KROS
Keros Therapeutics Inc
$11.71
AAPL
Apple Inc
$266.65
Key Metrics Comparison
| Metric | KROS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $351.88M | N/A | KROS |
| P/E Ratio | 5.02 | 32.80 | KROS |
| EPS (TTM) | $2.30 | $7.89 | AAPL |
| Revenue Growth | -0.9% | 0.2% | AAPL |
| Gross Margin | 47.9% | 47.3% | KROS |
Analyze KROS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KROS or AAPL a better investment?
Comparing KROS and AAPL: Keros Therapeutics Inc has a market cap of $351.88M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KROS and AAPL?
KROS (Keros Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KROS or AAPL?
Based on P/E ratios, KROS trades at a lower multiple (5.0x vs 32.8x).
Which is growing faster: KROS or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.9% for KROS.
Which company is more profitable: KROS or AAPL?
Keros Therapeutics Inc (KROS) has higher gross margins at 47.9% compared to 47.3% for AAPL.
Which is the larger company: KROS or AAPL?
Keros Therapeutics Inc (KROS) is larger with a market cap of $351.88M compared to N/A for AAPL.
Should I buy KROS or AAPL in 2026?
Both KROS and AAPL have investment merit. KROS trades at $11.71 while AAPL trades at $266.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KROS and AAPL stock?
Key differences: Market Cap ($351.88M vs N/A), P/E Ratio (5.0x vs 32.8x), Revenue Growth (-0.9% vs 0.2%), Gross Margin (47.9% vs 47.3%).